Itrabene Dermis (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. Without ergosterol, the fungal cell membrane becomes unstable, inhibiting growth and leading to cell death. This mechanism targets a wide range of pathogenic fungi.

The specific dose and duration are determined by the prescribing clinician based on the type and severity of the infection, patient weight, renal and hepatic function, and other individual factors. Itrabene Dermis is supplied in oral form, and the prescriber will select the appropriate regimen.

Itraconazole is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided unless the potential benefit justifies the risk. Limited data exist for breastfeeding; the drug can pass into milk, so use is generally discouraged while nursing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and necessary import documentation.

Compared with fluconazole, another azole, itraconazole has a broader spectrum against molds such as Aspergillus and dimorphic fungi, but it also has a higher potential for drug‑drug interactions and hepatic toxicity. Choice of therapy depends on the pathogen, infection site, patient comorbidities, and interaction profile.

Itrabene Dermis should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

The medication is taken orally, usually with food or a full glass of water to improve absorption. Swallow the tablet or capsule whole; do not crush or chew unless specifically instructed by a healthcare professional.

The most critical adverse effects include hepatotoxicity (elevated liver enzymes, hepatitis), severe skin reactions such as Stevens‑Johnson syndrome, and cardiac effects like QT‑interval prolongation that can lead to arrhythmias. Patients should be monitored regularly for signs of liver injury and cardiac abnormalities.

Itrabene Dermis is contraindicated in individuals with known hypersensitivity to itraconazole or any azole antifungal, in pregnant women, and in patients with severe hepatic impairment. Caution is also advised for those with existing heart failure or significant cardiac conduction disorders.